Skip to content

Restructuring the Alpha-Gamma Code in Aging Vision

Rescuing Visual Perception in Aging Adults by Restructuring the Alpha-Gamma Neural Code

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07208318
Enrollment
240
Registered
2025-10-06
Start date
2026-04-02
Completion date
2030-08-31
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Noninvasive Brain Stimulation, Visual Perception

Brief summary

Tests whether age-related visual deficits arise from disrupted alpha-gamma coupling in visual cortex (V1) and MT. Uses fMRI, source-resolved HD-EEG, and personalized complex-waveform HD-tACS to (1) quantify aging effects on phase-amplitude coupling, (2) drive PAC into a preferred "gamma-at-alpha-troughs" state, and (3) bidirectionally change perception by aligning gamma to alpha troughs vs peaks. Two five-day, double-blind, sham-controlled studies (n=120 each) target contrast sensitivity (V1) and 3D shape-from-motion (MT), aiming for mechanistic insight and remediation in older adults with implications for ADRD.

Detailed description

The project probes a causal account of age-related perceptual decline by focusing on alpha-gamma phase-amplitude coupling (PAC) in early visual cortex and area MT. The central hypothesis is that aging alters both the magnitude and phase structure of alpha-gamma interactions, degrading visual performance; restoring a preferred configuration-gamma power nested at alpha troughs-should improve perception. Multimodal methods combine structural/functional MRI, high-density EEG with source reconstruction, and individualized complex-waveform HD-tACS tuned to each participant's neuroanatomy and oscillatory frequencies. Three questions drive the work: (i) Do age-related deficits track changes in alpha-gamma PAC magnitude/phase? (ii) Can frequency-coupled HD-tACS enforce the preferred PAC configuration and enhance perception, especially in more impaired older adults? (iii) Is perception bidirectionally controllable by placing gamma at alpha troughs (facilitation) versus peaks (disruption)? Two specific aims implement matched, five-day, within-subjects, double-blind, sham-controlled experiments with 120 participants each. Aim 1 targets early visual cortex to test whether contrast sensitivity deficits scale with age, spatial frequency, and noise, and whether personalized HD-tACS can optimize PAC to improve contrast perception. Aim 2 targets MT to test whether 3D shape-from-motion (parallax) judgments decline with age as a function of surface-point lifetime and simulated depth, and whether trough- versus peak-aligned stimulation can restructure PAC to enhance motion-based shape perception. Outcomes will establish mechanistic links between PAC and visual aging and evaluate a noninvasive, personalized intervention path relevant to age-related decline and ADRD.

Interventions

Low-intensity and safe, noninvasive application of electrical current to the human scalp with the goal of gradually modulating levels of neuronal excitability.

Sponsors

Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18+ years of age or older * normal or corrected-to-normal visual acuity, color vision, and stereo vision

Exclusion criteria

* not pregnant, * no metal implants in head, * no implanted electronic devices, * no history of neurological problems or head injury, * no skin sensitivity, * no claustrophobia, * no dementia (normal Mini Mental State Examination between 24-30; Montreal Cognitive Assessment \> 25) * no depression (normal Beck Depression Inventory II \<13; Geriatric Depression Scale \< 10) * no ophthalmological diseases (e.g., strabismus, glaucoma, cataract, macular degeneration) * no history of psychosis * no cognitive deficits (MMSE score\>24; MoCA\>25) * cannot be taking any psychoactive medication.

Design outcomes

Primary

MeasureTime frameDescription
contrast sensitivityBaseline (pre-stimulation) and immediately post-stimulation, collected on each of the 5 study days.Orientation identification task
3D structural-from-motionBaseline (pre-stimulation) and immediately post-stimulation, collected on each of the 5 study days.surface point lifetime (unlimited, 12 and 2 successive views) on 3D discrimination task
phase-amplitude couplingBaseline (pre-stimulation) and immediately post-stimulation, collected on each of the 5 study days.alpha phase, gamma amplitude coupling (magnitude of coherency)

Countries

United States

Contacts

CONTACTRobert Reinhart, PhD
rmgr@bu.edu(617) 353-9481

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026